We are live on
!
Find out more
DCM
Discovery Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
218.96%
This Fund
S&P 500
This Quarter
Est. Return
+13.26%
1 Year Est. Return
+218.96%
3 Year Est. Return
+556.4%
5 Year Est. Return
+606.07%
10 Year Est. Return
+5,733.18%
AUM
$8.44B
AUM Growth
-$553M
(-6.2%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-16.51%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
146
New
35
Increased
17
Reduced
28
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$316M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$183M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$182M |
| 4 |
Pfizer
PFE
|
+$164M |
| 5 |
Morgan Stanley
MS
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$540M |
| 2 |
Apple
AAPL
|
+$246M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$231M |
| 4 |
Biogen
BIIB
|
+$204M |
| 5 |
Amazon
AMZN
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.44% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 11.95% |
| 4 | Communication Services | 10.61% |
| 5 | Technology | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMUSP
51
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $50.8M | 0.6% |
750,000
| – | – |
|
52
Nike
NKE
$62.7B
| $48M | 0.57% |
+767,600
| New | +$49.5M |
|
53
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $44M | 0.52% |
+2,214,860
| New | +$44.1M |
|
54
Cigna
CI
$76.1B
| $42.4M | 0.5% |
+290,048
| New | +$39.9M |
|
55
Qualcomm
QCOM
$160B
| $33.1M | 0.39% |
+662,000
| New | +$35.3M |
|
|
HRG
56
DELISTED
HRG Group, Inc.
HRG
| $32.2M | 0.38% |
+2,377,728
| New | +$31.2M |
|
|
ETFC
57
DELISTED
E*Trade Financial Corporation
ETFC
| $32.1M | 0.38% |
+1,083,250
| New | +$31.1M |
|
58
Darden Restaurants
DRI
$23.7B
| $31.7M | 0.38% |
497,577
-158,511
| -24% | -$9.21M |
|
59
TAL Education Group
TAL
$6.85B
| $31.5M | 0.37% |
4,061,730
+2,159,730
| +114% | +$14.7M |
|
|
TW
60
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $28.4M | 0.34% |
221,237
+53,737
| +32% | +$6.87M |
|
|
VMW
61
CALL
DELISTED
VMware, Inc
VMW
| $28.3M | 0.34% |
500,000
| – | – |
|
62
United Airlines
UAL
$40.1B
| $28M | 0.33% |
+489,000
| New | +$28.2M |
|
|
GRA
63
DELISTED
W.R. Grace & Co.
GRA
| $26.3M | 0.31% |
+263,675
| New | +$25.8M |
|
64
CALL
Broadcom
AVGO
$1.85T
| $26.1M | 0.31% |
+1,800,000
| New | +$23.4M |
|
65
Applied Materials
AMAT
$398B
| $24.4M | 0.29% |
+1,305,921
| New | +$22.7M |
|
|
AET
66
DELISTED
Aetna Inc
AET
| $23.1M | 0.27% |
+213,800
| New | +$23.1M |
|
67
Weibo
WB
$1.99B
| $21.5M | 0.26% |
1,103,623
+610,623
| +124% | +$10.5M |
|
68
Visa
V
$673B
| $20.3M | 0.24% |
262,200
-990,790
| -79% | -$76.7M |
|
|
JMEI
69
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $19.7M | 0.23% |
217,492
+8,730
| +4% | +$841K |
|
|
PNRA
70
DELISTED
Panera Bread Co
PNRA
| $16.4M | 0.19% |
84,000
-176,000
| -68% | -$32.7M |
|
71
Delta Air Lines
DAL
$58.3B
| $16.1M | 0.19% |
317,900
-1,815,700
| -85% | -$89.8M |
|
|
VNET
72
VNET Group
VNET
$2.08B
| $15.2M | 0.18% |
717,780
| – | – |
|
73
Atlassian
TEAM
$24.9B
| $15M | 0.18% |
+500,000
| New | +$14.2M |
|
74
GoPro
GPRO
$124M
| $14.9M | 0.18% |
+829,000
| New | +$19.2M |
|
|
ESPR
75
DELISTED
Esperion Therapeutics
ESPR
| $14.9M | 0.18% |
667,532
+143,332
| +27% | +$3.62M |
|
Similar funds
CC
RCAG
HC
QOP
6CM
HCL
RIL
AAA
Discovery Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Discovery Capital Management held 146 positions worth $8.44B, down 6.2% from $8.99B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Discovery Capital Management withdrew a net $1.39B in Q4 2015, closing 55 positions and reducing 28 holdings. Its most notable exit was Allergan plc, an estimated $540M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Discovery Capital Management opened a new position in Teva Pharmaceuticals worth $194M.
- Discovery Capital Management's largest Q4 2015 buy was Teva Pharmaceuticals: 2,958,200 shares worth $194M.
- Discovery Capital Management added most to Alibaba in Q4 2015, an estimated $316M increase.
- Discovery Capital Management's biggest Q4 2015 reduction was Amazon, cutting an estimated $191M.
- Discovery Capital Management fully exited Allergan plc in Q4 2015, selling an estimated $540M.
- Discovery Capital Management's ten largest holdings make up 41% of its $8.44B portfolio in Q4 2015.
- Discovery Capital Management opened 35 new positions and closed 55 in Q4 2015.
- Discovery Capital Management's portfolio value fell 6.2% quarter-over-quarter to $8.44B.
Based on Discovery Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.